26/06/2026
Around 145,000 Australians are living with type 1 diabetes, a lifelong autoimmune disease that currently has no cure.
For children like Piper, whose story we shared earlier, it means a life of constant blood glucose monitoring, insulin injections and careful daily management.
At Centenary's Centre for Biomedical AI, Dr Lise Hunault is working to change that future. 🔬
Her research is focused on improving a promising new treatment approach that uses lab-grown insulin-producing cells to provide a new source of insulin in the body. One of the biggest challenges is ensuring these cells survive after transplantation.
By making the cells more resilient, Dr Hunault hopes to overcome this hurdle and bring us closer to treatments that could dramatically reduce the burden of type 1 diabetes.
"I hope for a world where treatments that come from my research can keep glucose levels stable for years, giving people a real sense of freedom in their everyday lives," says Dr Hunault.
For families like Piper's, this research offers hope for a future with fewer injections, less uncertainty and a better quality of life.
Support our EOFY Appeal before 30th June for your donation to be a tax deductible gift. 🎁 Donate today: https://bit.ly/4eItca6